Efficacy and safety data from elderly patients with pretreated advanced melanoma in the Italian cohort of ipilimumab expanded access programme (EAP).
Vanna Chiarion-Sileni
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche
Jacopo Pigozzo
No relevant relationships to disclose
Paolo Antonio Ascierto
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; MedImmune; MSD; Novartis; Roche/Genentech
Honoraria - Bristol-Myers Squibb; MSD; Roche/Genentech
Michele Maio
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Riccardo Danielli
No relevant relationships to disclose
Michele Del Vecchio
Research Funding - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Novartis; Roche
Laura Ridolfi
No relevant relationships to disclose
Federica De Galitiis
Honoraria - Bristol-Myers Squibb
Alessandro Testori
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; IGEA; Merck; Roche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; IGEA; Merck; Roche
Other Remuneration - IGEA; Oncovision
Emilia Cocorocchio
No relevant relationships to disclose
Francesco Cognetti
No relevant relationships to disclose
Virginia Ferraresi
No relevant relationships to disclose
Maria Grazia Bernengo
Consultant or Advisory Role - Bristol-Myers Squibb
Michele Guida
No relevant relationships to disclose
Andrea Antonuzzo
No relevant relationships to disclose
Mario Mandala
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Giorgio Parmiani
Consultant or Advisory Role - CureVac
Other Remuneration - Recombio
Vito Vanella
No relevant relationships to disclose
Massimo Aglietta
No relevant relationships to disclose
Paola Queirolo
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche